Paul Gillum, MD
Dermatopathology · Norman, OKNPI 1982602025
Payments from drug & device makers
Across 130 payments — averaging $6234.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$443K
- Eli Lilly$158K
- E.r. Squibb & Sons, L.L.C.$131K
- Regeneron$55K
- Astrazeneca UK Limited$17K
- Janssen Research & Development, LLC$6K
- plus $14 from 1 others
Across 2 payments — averaging $381.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$763
What the payments were for
- Food & beverage$14100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 96 | $443,031 |
| Eli Lilly | 7 | $158,445 |
| E.r. Squibb & Sons, L.L.C. | 4 | $130,674 |
| Regeneron | 14 | $54,971 |
| Astrazeneca UK Limited | 4 | $17,151 |
| Janssen Research & Development, LLC | 4 | $6,221 |
| Hologic Sales And Service, LLC | 1 | $14 |
How this compares
Too few dermatopathology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.